- Global Health (GLH) enters a trading halt while it plans an upcoming capital raising
- The company will remain in the halt until June 15 or when more details are released, whichever occurs first
- On May 31, Global Health appointed Michael Davies as CEO to drive growth following significant investment in its software-as-a-service products
- Mr Davies has a background in the public and private sectors, leading technology adoption, driving sales and implementing market strategies
- Shares in Global Health last traded at 79 cents on June 4
Global Health (GLH) has entered a trading halt while it plans an upcoming capital raising.
The company will remain in the halt until June 15 or when more details are released, whichever occurs first.
Global Health is yet to disclose how much it intends to raise or what it will use the funds for once they have been received.
On May 31, Global Health appointed Michael Davies as CEO to drive growth following significant investment in its software-as-a-service products.
Mr Davies has a background in the public and private sectors, leading technology adoption, driving sales and implementing market strategies.
He has spent the past 20 years working with the likes of Telstra and Optus and was most recently Head of Revenue at Macquarie Telecom.
Mr Davies will be taking over from current CEO and Managing Director Mathew Cherian, who will transition to the new role of Executive Director.
In this new role, Mr Cherian will lead Global Health’s strategic focus and expansion into markets, and ensure a smooth transition for Mr Davies.
Shares in Global Health last traded at 79 cents on June 4. The company has a $33.36 million market cap.